HR
GILD icon

Hayden Royal’s Gilead Sciences GILD Stock Holding History

Hayden Royal’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$229K Sell
3,154
-48
-1% -$3.31K 0.54% 66
2021
Q3 		$224K Buy
3,202
+1
+0% +$70 0.37% 74
2021
Q2 		$220K Buy
+3,201
New +$214K 0.12% 172
2020
Q2 		– Sell
-3,352
Closed -$251K – 193
2020
Q1 		$251K Sell
3,352
-12
-0.4% -$829 0.15% 173
2019
Q4 		$225K Buy
+3,364
New +$219K 0.11% 192
2019
Q1 		– Sell
-3,962
Closed -$248K – 151
2018
Q4 		$248K Buy
+3,962
New +$277K 0.13% 162

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hayden Royal's GILD Position: Q4 2021 in Review

Hayden Royal reduced its Gilead Sciences (GILD) stake by 1.5% in Q4 2021, selling an estimated $3.31K and leaving 3,154 shares worth $229K. The position accounts for 0.54% of the portfolio, ranked #66.

Hayden Royal first reported a position in GILD in Q4 2018 and has held it in 6 quarters since. The position peaked at $251K in Q1 2020. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Hayden Royal held 3,154 shares of Gilead Sciences worth $229K as of Q4 2021.
  • Hayden Royal sold 48 Gilead Sciences shares in Q4 2021, an estimated $3.31K.
  • Gilead Sciences made up 0.54% of Hayden Royal's portfolio in Q4 2021, its #66 holding.
  • Hayden Royal first reported a position in Gilead Sciences in Q4 2018 and has held it in 6 quarters since.
  • Hayden Royal's Gilead Sciences position peaked at $251K in Q1 2020.
  • 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Hayden Royal's 13F filing for Q4 2021, filed 7 Feb 2022.